...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: New PP on Aug 13
Reply New Message
Back To Forum List View
New PP on Aug 13
5
fouremm
Aug 19, 2019 11:07PM
Re: New PP on Aug 13
4
RVXoldtimer
Aug 20, 2019 03:25AM

Thats a nice vote of Confidence  for the science from KD/ Eastern, as well as exercising the 5,000,000 RVX  warrants at .75cents . Tells me Eastewrn likes what they see or hear so far and this late in the BETONMACE trial

7 Recommendations
Re: New PP on Aug 13
2
Toinv
Aug 21, 2019 07:40AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply